4 days ago
1
Win McNamee/Getty Images News
Carlyle Group (NASDAQ:CG) is set to sell up to a 10% stake in Indian drugmaker Piramal Pharma, in a deal that could fetch the U.S.-based private equity firm 26B-27B rupees ($304.3M-$316.0M), Moneycontrol reported on Thursday, citing sources.
Carlyle (NASDAQ:
English (US) ·